You Won't Regret Reading the Facts on Intuitive Surgical.

Large-cap Health Care company Intuitive Surgical has logged a -1.0% change today on a trading volume of 601,457. The average volume for the stock is 1,884,396.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. Based in Sunnyvale, United States the company has 12,120 full time employees and a market cap of $108,651,184,128.

The company is now trading -6.61% away from its average analyst target price of $330.44 per share. The 24 analysts following the stock have set target prices ranging from $240.0 to $400.0, and on average give Intuitive Surgical a rating of buy.

Over the last 52 weeks, ISRG stock has risen 16.0%, which amounts to a -1.0% difference compared to the S&P 500. The stock's 52 week high is $358.07 whereas its 52 week low is $222.65 per share. With its net margins declining an average -4.7% over the last 6 years, Intuitive Surgical may not have a strong enough profitability trend to support its stock price.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%) YoY Growth (%)
2023 6,850,800 1,543,300 23 4.55
2022 6,222,200 1,344,400 22 -26.67
2021 5,710,100 1,728,100 30 25.0
2020 4,358,400 1,066,800 24 -22.58
2019 4,478,500 1,381,800 31 3.33
2018 3,724,200 1,127,900 30
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS